Категории

Overview of Novel Therapy for Advanced-Stage NSCLC

Опубликовано: 05 Сентябрь 2019
на канале: OncLive
91
0

Suresh Ramalingam, MD, shares insight on the evolving therapeutic landscape of advanced non–small cell lung cancer management

Смотрите видео Overview of Novel Therapy for Advanced-Stage NSCLC онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь OncLive 05 Сентябрь 2019, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 91 раз и оно понравилось 0 людям.

play_arrow
529
5

1/6 scale action figures Mad Max

1/6 scale action figures Mad Max

play_arrow
75,881
4.5 тыс

This is the NEW Dream VS Technoblade! (old)

This is the NEW Dream VS Technoblade! (old)
play_arrow
19,979
301

Кармен-фильм | Георгий Свиридов. Метель. Романс нежности и веры - Руслан Богатырев

Кармен-фильм | Георгий Свиридов. Метель. Романс нежности и веры - Руслан Богатырев
play_arrow
44,811
96

O.A.R. - Dangerous Connection (Lyrics)

O.A.R. - Dangerous Connection (Lyrics)
play_arrow
15
0

Бехтарин Азон

Бехтарин Азон
play_arrow
744
13

Посадка саженцев хвойных с ОКС в открытый грунт

Посадка саженцев хвойных с ОКС в открытый грунт
play_arrow
2
0

NSA Best Practices for Securing Your Home Network - 23rd February 2023

NSA Best Practices for Securing Your Home Network - 23rd February 2023
play_arrow
35
0

watch these discord pedophiles fight themselves

watch these discord pedophiles fight themselves
Похожие видео
play_arrow
Precision Medicine in Metastatic Triple Negative Breast Cancer

Precision Medicine in Metastatic Triple Negative Breast Cancer
play_arrow
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
play_arrow
EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
play_arrow
OncLive News Network On Location: ASCO 2020 Day 1

OncLive News Network On Location: ASCO 2020 Day 1
play_arrow
Diagnosis of Neurofibromatosis Type 1

Diagnosis of Neurofibromatosis Type 1
play_arrow
Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer
play_arrow
Novel Treatments in HER2-Positive Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer
play_arrow
Lurbinectedin’s Role in Managing SCLC

Lurbinectedin’s Role in Managing SCLC
play_arrow
Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma

Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma
play_arrow
Therapy Options for Hepatitis B/C–Related HCC

Therapy Options for Hepatitis B/C–Related HCC
play_arrow
Treating Patients With Essential Thrombocytopenia

Treating Patients With Essential Thrombocytopenia
play_arrow
Biology of Clear Cell Renal Cell Carcinoma

Biology of Clear Cell Renal Cell Carcinoma
play_arrow
The Use of Ruxolitinib in Myelofibrosis

The Use of Ruxolitinib in Myelofibrosis
play_arrow
Current Treatment Landscape of Soft Tissue Sarcoma

Current Treatment Landscape of Soft Tissue Sarcoma
play_arrow
Diagnostic Testing Procedure for Soft Tissue Sarcoma

Diagnostic Testing Procedure for Soft Tissue Sarcoma
play_arrow
Treatment Landscape of Castrate-Resistant Prostate Cancer

Treatment Landscape of Castrate-Resistant Prostate Cancer
play_arrow
Lenalidomide in Del 5q MDS

Lenalidomide in Del 5q MDS
play_arrow
MDS: Low-Risk Disease Treatment Options

MDS: Low-Risk Disease Treatment Options
play_arrow
Neoadjuvant Treatment for Triple-Negative Breast Cancer

Neoadjuvant Treatment for Triple-Negative Breast Cancer
play_arrow
Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice
play_arrow
Dr. Tsao on Rationale for Staging Renal Cell Carcinoma

Dr. Tsao on Rationale for Staging Renal Cell Carcinoma
play_arrow
Cirrhosis Prognosis: The Child-Pugh Score

Cirrhosis Prognosis: The Child-Pugh Score
play_arrow
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
play_arrow
Dr. Corcoran on Targeting HER2 Amplification in CRC

Dr. Corcoran on Targeting HER2 Amplification in CRC